Company: CERO
Filing Date: 2025-10-14
Form Type: 8-K
Source: 0001213900-25-098421
Chunk: 2

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-10-14
Form: 8-K
Item: Item 9.01
Chunk 2
---
 Securities and Exchange Commission, including its Annual Report on Form 10-K, filed on April
15, 2025, and subsequent Quarterly Reports on Form 10-Q and the documents incorporated by reference therein. The risks described in the
Company’s filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time, and
it is not possible to predict all such risk factors, nor can the Company assess the impact of all such risk factors on its business, or
the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking
statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which
speak only as of the date hereof. All forward-looking statements made by the Company or persons acting on its behalf are expressly qualified
in their entirety by the foregoing cautionary statements. The Company undertakes no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law.

SIGNATURE

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

  Dated: October 14, 2025      CERO THERAPEUTICS HOLDINGS, INC.                               
 ──────────────────────────────────────────────────────────────────────────────────────────────
                               By:                                   /s/ Chris Ehrlich        
                               Name:                                 Chris Ehrlich            
                               Title:                                Chief Executive Officer